DS2 - EFFECTIVENESS AND SAFETY OF STANDARD AND REDUCED DOSES OF DABIGATRAN VERSUS RIVAROXABAN IN NON-VALVULAR ATRIAL FIBRILLATION- A COHORT STUDY IN THE SNDS FRENCH NATIONWIDE CLAIMS DATABASE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.043
https://www.valueinhealthjournal.com/article/S1098-3015(18)33343-6/fulltext
Title :
DS2 - EFFECTIVENESS AND SAFETY OF STANDARD AND REDUCED DOSES OF DABIGATRAN VERSUS RIVAROXABAN IN NON-VALVULAR ATRIAL FIBRILLATION- A COHORT STUDY IN THE SNDS FRENCH NATIONWIDE CLAIMS DATABASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33343-6&doi=10.1016/j.jval.2018.09.043
First page :
Section Title :
Open access? :
No
Section Order :
2313